Therapy News and Research

RSS

Adaptive platform trial shows promise for finding new glioblastoma therapies

An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that benefit patients.

19 Sep 2023

New CAR T cell therapy approach minimizes severe side effects

In recent years, cancer researchers have hailed the arrival of chimeric antigen receptor T cell (CAR T) therapy, which has delivered promising results, transforming the fight against various forms of cancer. The process involves modifying patients' T-cells to target cancer cells, resulting in remarkable success rates for previously intractable forms of cancer.

19 Sep 2023

New research offers insight about the reason mitochondrial DNA is maternally inherited

New research provides insight about the bedrock scientific principle that mitochondrial DNA - the distinct genetic code embedded in the organelle that serves as the powerplant of every cell in the body - is exclusively passed down by the mother.

19 Sep 2023

Uniink: A new 3D bioprinted cell therapy approach for Type 1 diabetes

Javier Ramón Azcón, an ICREA research professor and the leader of the Biosensors for Bioengineering group at the Institute for Bioengineering of Catalonia (IBEC), has been granted an "ERC Proof of Concept Grant."

18 Sep 2023

Researchers identify key mechanisms to address future treatments for hereditary blindness

There are still many enigmas about the mechanism of action of the CERKL gene, which causes retinitis pigmentosa and other hereditary vision diseases.

18 Sep 2023

Study highlights a promising therapy to mitigate spaceflight-induced bone loss

A new study published in a Nature Partner Journal, npj Microgravity, finds an engineered compound given to mice aboard the International Space Station (ISS) largely prevented the bone loss associated with time spent in space.

18 Sep 2023

New immunoregulatory protein linked to autoimmune disease

Autoimmune diseases are complex illnesses, the causes of which are diverse and have not yet been fully explained.

18 Sep 2023

Researchers conduct comprehensive psychological evaluation of university students

The prevalence rates of stress, depression, anxiety, insomnia, mania, suicidal ideation, loneliness, and psychotic experiences among university-going students in the UK.

18 Sep 2023

Broken String Biosciences closes $15M series A funding round

Broken String Biosciences today announced that it has closed a $15 million Series A investment round.

From Broken String Biosciences 18 Sep 2023

Wireless molecular-electrical communications for tumor-cell-induced apoptosis

Researchers utilize electricity generated by wireless-induced redox interactions at bio-nanoantennae to cause apoptosis in cancerous cells.

18 Sep 2023

Physical therapy can help reduce risk of dizziness-induced injury

The association between symptomatic dizziness and vestibular disorders and the subsequent risk of falls and other injuries.

18 Sep 2023

COVID-19 pandemic fails to deter osteoporosis treatment initiation: New study reveals steady rates

Whether patients with newly diagnosed osteoporosis received delayed pharmacologic treatment due to the COVID-19 pandemic.

18 Sep 2023

MDMA-assisted therapy reduces PTSD symptoms dramatically

New study shows MDMA-assisted therapy significantly reduces symptoms in individuals with moderate to severe PTSD, outperforming traditional therapy and medications. The study, covering multiple sites in the U.S. and Israel, indicates that while effective, further research is needed to explore potential side effects and effectiveness across diverse groups.

17 Sep 2023

Stuart Orkin receives the third Elaine Redding Brinster Prize for development of sickle cell disease therapy

For his work discovering the basis for hemoglobin gene switching and applying those insights to develop a therapy for sickle cell disease and other blood diseases, the Institute for Regenerative Medicine at the University of Pennsylvania awarded Stuart Orkin, MD the third Elaine Redding Brinster Prize in Science or Medicine.

15 Sep 2023

Purdue researcher receives $1.38 million to fight against drug-resistant malaria in developing countries

A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries.

15 Sep 2023

Oto and Lindus Health launch a remote trial to increase patient access to tinnitus therapy

Digital health company Oto and clinical trial start-up Lindus Health today announced the launch of a fully remote, digital trial to increase patient access to life-changing tinnitus therapy.

15 Sep 2023

How does Helicobacter pylori infection influence rheumatoid arthritis?

The association between Helicobacter pylori infection and rheumatoid arthritis (RA).

15 Sep 2023

New genetic test reveals a person’s predisposition to happiness

Your happiness levels aren't only based on external events. Genome testing can reveal how happy and optimistic you are predisposed to be. A leading testing expert reveals how variations of a key gene, CNR1, may have a significant impact on your level of happiness.

15 Sep 2023

Is there an association between waist-calf circumference ratio and all-cause and cause-specific mortality?

How anthropometric measures like WCR are associated with cause-specific and all-cause mortality in elderly adults.

15 Sep 2023

N-acetylglucosamine reduces multiple inflammation and neurodegeneration markers in MS patients

UCI researchers have found that a simple sugar, N-acetylglucosamine, reduces multiple inflammation and neurodegeneration markers in people who suffer from multiple sclerosis (MS).

14 Sep 2023

Therapy News and Research

Adaptive platform trial shows promise for finding new glioblastoma therapies

New CAR T cell therapy approach minimizes severe side effects

New research offers insight about the reason mitochondrial DNA is maternally inherited

Uniink: A new 3D bioprinted cell therapy approach for Type 1 diabetes

Researchers identify key mechanisms to address future treatments for hereditary blindness

Study highlights a promising therapy to mitigate spaceflight-induced bone loss

New immunoregulatory protein linked to autoimmune disease

Researchers conduct comprehensive psychological evaluation of university students

Broken String Biosciences closes $15M series A funding round

Wireless molecular-electrical communications for tumor-cell-induced apoptosis

Physical therapy can help reduce risk of dizziness-induced injury

COVID-19 pandemic fails to deter osteoporosis treatment initiation: New study reveals steady rates

MDMA-assisted therapy reduces PTSD symptoms dramatically

Stuart Orkin receives the third Elaine Redding Brinster Prize for development of sickle cell disease therapy

Purdue researcher receives $1.38 million to fight against drug-resistant malaria in developing countries

Oto and Lindus Health launch a remote trial to increase patient access to tinnitus therapy

How does Helicobacter pylori infection influence rheumatoid arthritis?

New genetic test reveals a person’s predisposition to happiness

Is there an association between waist-calf circumference ratio and all-cause and cause-specific mortality?

N-acetylglucosamine reduces multiple inflammation and neurodegeneration markers in MS patients

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News